GARP Research Downgrades Genomic Health Inc. (GHDX) to Neutral
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Rating Summary:
3 Buy, 15 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
3 Buy, 15 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
GARP Research downgraded Genomic Health Inc. (NASDAQ: GHDX) from Buy to Neutral.
For an analyst ratings summary and ratings history on Genomic Health Inc. click here. For more ratings news on Genomic Health Inc. click here.
Shares of Genomic Health Inc. closed at $30.00 yesterday.
For an analyst ratings summary and ratings history on Genomic Health Inc. click here. For more ratings news on Genomic Health Inc. click here.
Shares of Genomic Health Inc. closed at $30.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades oOh!media (OML:AU) to Equalweight
- JPMorgan Downgrades Kuaishou Technology (1024:HK) to Neutral
- RBC Capital Downgrades Super Retail Group Ltd. (SUL:AU) to Sector Perform
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
